Related Experiment Video
Updated: May 25, 2026

Murine Model of Leukemia Relapse to Induction Chemotherapy for Acute Lymphoblastic Leukemia
Published on: October 17, 2025
Successful treatment of childhood hypocellular acute myeloid leukemia
Masaki Yamamoto1, Tsukasa Hori, Naoki Hatakeyama
1Department of Pediatrics †Surgical Pathology, Sapporo Medical University School of Medicine, Sapporo, Japan. ymasaki@sapmed.ac.jp
Abstract:
Hypocellular acute myeloid leukemia (AML) is extremely rare in childhood. We report on a 7-year-old girl with hypocellular AML who was treated successfully with granulocyte-colony stimulating factor (G-CSF) and combined chemotherapy. High-dose G-CSF induced complete remission and she subsequently received reduced intensity conditioning and unrelated cord blood transplantation; however, this resulted in early rejection. After a complete hematological recovery, she received 3 courses of combination chemotherapy oriented toward AML. She has remained in complete remission for over 1 year after the completion of the therapy. G-CSF effectively induced remission, and combination chemotherapy has been proven to be feasible for patients with childhood hypocellular AML.
